|
Targeted Candidalysin Binders for Fungal Infection Control
Application
A theranostic scaffold-derived protein that neutralizes candidalysin toxin.
Key Benefits
Different mechanism of action compared to current antifungal drugs, reducing the risk of resistance.
Derived from human protein for lower immune response and produced cost-effectively in simple bacterial media.
Small size improves tissue penetration...
Published: 1/26/2026
Contributor(s): Sohail Khoshnevis, Eric J. Sundberg, Maros Huliciak
|
